Fondazione Paolo Procacci. “EMERGING DRUGS OF ABUSE IN THE CHRONIC PAIN POPULATION: A CLINICAL PHARMACOLOGY PERSPECTIVE ON KRATOM, NOVEL SYNTHETIC OPIOIDS, DESIGNER BENZODIAZEPINES, GABAPENTINOIDS, XYLAZINE, AND KETAMINE: F. Breve1, G. Varrassi2, J. Pergolizzi3, R. Raffa4 | 1Mid Atlantic PharmaTech Consultants LLC, Ventnor City, NJ, USA; Temple University School of Pharmacy, Philadelphia, PA, USA; 2Fondazione Paolo Procacci, Rome, Italy; 3NEMA Research Inc., Naples, FL, USA; 4Temple University School of Pharmacy, Philadelphia, PA, USA; University of Arizona College of Pharmacy, Tucson, AZ, USA”. Advancements in Health Research, vol. 3, no. s1, May 2026, https://doi.org/10.4081/ahr.2026.152.